home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification

prev / next

 
 

registry of biomedical companies

 
  March 20, 2010

promoting the transfer of scientific know-how between industry and academia

 
 
Registry of biomedical companies:

[(] [3] [4] [7] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] [^] 1153 active entries

4Vision Marketing

Zuidbrink 24
Westerbork, 9431 AR
Netherlands

Phone: +31 593 370006
Fax: +31 84 7231590
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Description:

4Vision Marketing brings buyers and sellers of advanced technology services together. We do not execute these services ourselves but work with partners who are experts in their field and focused on a limited number of specialist services.

 

4Vision Marketing offers specialists drug discovery and drug development services to European pharma & biotech companies.

 

We unite independent specialist companies all focused on specific services needed in drug discovery & drug development.

Ø Early drug discovery and lead generation

Ø Analysis and structure determination of compounds

Ø Formulation services

Ø Scale up and manufacturing of biological compounds & NCE’s

Ø Preclinical services

Ø Clinical trial services

Ø Oncology services

Apart from the above mentioned services, we can also provide you with expert knowledge in regulatory affairs, certification and QC/QA. 

 

In- & out-licensing of products and technology

We assist companies with their in- & out-licensing efforts, in Europe and the US. 

Our current projects are in new antibody lead generation, an early stage double targeting system to treat disease in the gastro-intestinal tract, a probiotics formulation technology & a food grade compound with applications in treatment of obesity. We are also currently working to find potential new early compounds for the treatment of RA & OA.


Selected Categories:
Product Company   Service Company
Consulting
- General
- Strategic
Contract
- Production
- Research
- Services
Laboratory
- Analytical

Last update of this entry: December 02, 2008

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2010 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.